Pulmonary complications of liver transplantation

Clinical Pulmonary Medicine

Volumn 5, Issue 1, 1998, Pages 69-80

  Soubani, Ayman O ^a,c   Rohrer, Richard J ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Complications; Infection; Liver disease; Organ transplantation; Pulmonary disease

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; COTRIMOXAZOLE; ERYTHROMYCIN; GANCICLOVIR; IMIPENEM; NYSTATIN; VITAMIN D;

ATELECTASIS; BACTERIAL PNEUMONIA; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIVER TRANSPLANTATION; LUNG CALCIFICATION; LUNG EDEMA; LUNG MYCOSIS; LUNG TUBERCULOSIS; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PROTOZOAL INFECTION; REVIEW; RISK ASSESSMENT; VIRUS PNEUMONIA;

EID: 0031881345     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199801000-00009     Document Type: Review

References (148)

1. Starzl TE, Marchioro TL, Von Kaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-76.
2. Starzl TE, Groth CG, Brettschneider L, et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968;169:392-415.
3. Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 patients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;2:1003-6.
4. Starzl TE, Iwatsuki S, Klintmalm G, et al. Liver transplantation, 1980, with particular reference to cyclosporin A. Transplant Proc 1981;13:281-5.
5. Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schroter GP. Liver transplantation with the use of cyclosporin A and prednisone. N Engl J Med 1981;305:266-9.
6. Annual report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Bethesda (MD): Division of Organ Transplantation, Bureau of Health Resources Development, US Department of Health and Human Services; 1994.
7. Ringe B. Quadrennial review on liver transplantation. Am J Gastroenterol 1994;89(8 Suppl):S18-S26.
8. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med 1989;321: 1014-22.
9. Hockerstedt K. Liver transplantation: a changing concept. Transplant Proc 1994;26: 1706-7.
10. Consensus statement on indications for liver transplantation. Paris, June 22-23, 1993. Hepatology 1994;20:63S-68S.
11. United Network for Organ Sharing (UNOS). Facts about transplantation in the United States. UNOS Update 1993;9:35.
12. Maddrey WC, Van Thiel DH. Liver transplantation: an overview. Hepatology 1988;8: 948-59.
13. Moreno Gonzalez E, Gomez R, Garda I, et al. Liver transplantation in malignant primary hepark neoplasms. Am J Surg 1992;163:395-400.
14. Wood RP, Ozaki CF, Katz SM, Monsour HP Jr, Dyer CH, Johnston TD. Liver transplantation: the last ten years. Surg Clin North Am 1994;74:1133-54.
15. Thompson AB, Rickard KA, Shaw BW, et al. Pulmonary complications and disease severity in adult liver transplant recipients. Transplant Proc 1988;20(1 Suppl):646-9.
16. Afessa B, Gay PC, Plevak DJ, Swensen SJ, Patel HG, Krowka MJ. Pulmonary complications of orthotopic liver transplantation. Mayo Clin Proc 1993;68:427-34.
17. Jensen WA, Rose RM, Hammer SM, et al. Pulmonary complications of orthotopic liver transplantation. Transplantation 1986;42: 484-90.
18. Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983;36:259-67.
19. Singh N, Gayowski T, Wagener M, Yu VL. Infectious complications in liver transplant recipients on tacrolimus: prospective analysis of 88 consecutive liver transplants. Transplantation 1994;58:774-8.
20. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: analysis of 101 consecutive cases. Medicine (Baltimore) 1988;67:132-43.
21. Singh N, Gayowski T, Wagener M, Marino IR, Yu VL. Pulmonary infections in liver transplant recipients receiving tacrolimus: changing pattern of microbial etiologies. Transplantation 1996;61:396-401.
22. Ho M, Wajszczuk CP, Hardy A, et al. Infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplant Proc 1983;15:2768-72.
23. Golfieri R, Giampalma E, Sama C, et al. Pulmonary complications following liver transplant: radiologic patterns and epidemiologic considerations in 100 cases. Rays 1994;19:319-38.
24. Kusne S, Dummer JS, Singh N, et al. Fungal infections after liver transplantation. Transplant Proc 1988;20:650-1.
25. Castaldo P, Stratta RJ, Wood P, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991:126: 149-56.
26. Colonna JO, Winston DJ, Brill JE, et al. Infectious complications in liver transplantation. Arch Surg 1988;123:360-4.
27. Martin M, Kusne S, Alessiani M, Simmons R, Starzl TE. Infections after liver transplantation: risk factors and prevention. Transplant Proc 1991;23:1929-30.
28. Stoblen F, Blumhard G, Kaisers U, Raakov R, Bechstein WO, Neuhaus P. Outcome of severe pneumonias after orthotopic liver transplantation. Transplant Proc 1994;26:3681-2.
29. Schroter GP, Hoelscher M, Putnam CW, Porter KA, Hansbrough JF, Starzl TE. Infection-complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg 1976;111:1337-47.
30. Ettinger NA, Trulock EP. Pulmonary considerations of organ transplantation (part 1). Am Rev Respir Dis 1991;143:1386-405.
31. Nicholson V, Johnson PC. Infectious complications in solid organ transplant recipients. Surg Clin North Am 1994;74:1223-45.
32. Raakow R, Steffen R, Lefebre B, Bechstein WO, Blumhardt G, Neuhaus P. Selective bowel decontamination effectively prevents Gram-negative bacterial infections after liver transplantation. Transplant Proc 1990;22: 1556-7.
33. Wiesner RH. Selective bowel docontamination for infection prophylaxis in liver transplantation patients. Transplant Proc 1991;23: 1927-8.
34. Gorensek MJ, Carey WD, Washington JA, Vogt DP, Broughan TA, Westveer MK. Selective bowel decontamination with quinolones and nystatin reduces Gram-negative and fungal infections in ortholopic liver transplant recipients. Cleve Clin J Med 1993;60:139-44.
35. Ampel NM, Wing EJ. Legionella infection in transplant recipients. Semin Respir Infect 1990;5:30-7.
36. Singh N, Muder RR, Yu VL, Gayowski T. Legionella infection in liver transplant recipients: implications for management. Transplantation 1993;56:1549-51.
37. Edelstein PH. Legionnaires' disease. Clin Infect Dis 1993;16:741-7.
38. Prodinger WM, Bonatti H, Allerberger F, et al. Legionella pneumonia in transplant recipients: a cluster of cases of eight years duration. J Hosp Infect 1994;26:191-202.
39. Forbes GM, Harvey FA, Philpott-Howard JN, et al. Nocardiosis in liver transplantation: variation in presentation, diagnosis, and therapy. J Infect 1990;20:11-9.
40. Raby N, Forbes G, Williams R. Nocardia infection in patients with liver transplants or chronic liver disease: radiologic findings. Radiology 1990;174:713-6.
41. Dummer S, Kusne S. Liver transplantation and related infections. Semin Respir Infect 1993;8:191-8.
42. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-88.
43. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzell JZ. Candida sepsis: pathogenesis and principles of treatments. Ann Surg 1974;179: 697-711.
44. Wiesner RH, Hermans PE, Rakela J, et al. Selective bowel decontamination to decrease Gram-negative aerobic bacterial and candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988;45:570-4.
45. Castaldo P, Stratta RJ, Wood RP, et al. Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc 1991;23:1517-9.
46. Castaldo P, Stratta RJ, Wood RP, et al. Fungal infections in liver allograft recipients. Transplant Proc 1991;23:1967.
47. Paya CV, Hermans PE, Washington JA, et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989;64: 555-64.
48. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994;170:644-52.
49. Rossi G, Tortorano AM, Viviani MA, et al. Aspergillus fumigatus infections in liver transplant patients. Transplant Proc 1989;21: 2268-70.
50. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985;40:347-53.
51. Torre-Cisneros J, Manez R, Kusne S, Alessiani M, Martin M, Starzl TE. The spectrum of Aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc 1991;23: 3040-1.
52. Kusne S, Torre-Cisneros J, Manez R, et al. Factors associated with invasive lung Aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992;166:1379-83.
53. Dominguez E. Long-term infectious complications of liver transplantation. Semin Liver Dis 1995;15:133-8.
54. Tollemar J, Ericzon BG, Holmberg K, Andersson J. The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplant Proc 1990;22:242-4.
55. Ringden O, Tollemar J, Dahllof G, Tyden C. High cure rate of invasive fungal infections in immunocompromised children using AmBisome. Transplant Proc 1994;26:175-7.
56. Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Liposomal amphotertein B prevents invasive fungal infections in liver transplant recipients: a randomized, placebo-controlled study. Transplantation 1995;59:45-50.
57. Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis 1996;22:537-49.
58. Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RA, Paya CV. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am 1993;22:351-66.
59. Fujinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means of graft rejection and immunosuppression. J Virol 1988;62:100-5.
60. Balfour HH, Heussner RC. Cytomegalovirus infections and liver transplantation: an overview. Transplant Proc 1993;25:2012-3.
61. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989;110:1001-6.
62. Hibberd PL, Snydman DR. Cytomegalovirus infection in organ transplant recipients. Infect Dis Clin North Am 1995;9:863-77.
63. Paya CV, Hermans PE, Wiesner RH, et al. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989;160:752-8.
64. Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989;124: 1443-9.
65. Ho M. Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transplant Proc 1991;23(3 Suppl):104-8.
66. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective time-dependent analysis. J Hepatol 1993;18:185-95.
67. Gorensek MJ, Carey WD, Vogt D, Goormastic M. A multivariate analysis of risk factors for cytomegalovirus infection in liver transplant recipients. Gastroenterology 1990;98:1326-32.
68. Portela D, Patel R, Larson-Keller JJ, et al. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis 1995;171: 1014-8.
69. Martin M. Antiviral prophylaxis for CMV infection in liver transplantation. Transplant Proc 1993;25:10-4.
70. George MJ, Snydman DR, Werner BG, et al. Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. Transplant Proc 1993;25(4 Suppl ):22-4.
71. Stratta RJ. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc 1993;25 (4 Suppl ):15-21.
72. Falagas ME, Snydman DR. Recurrent cytomegalovirus disease in solid-organ transplant recipients. Transplant Proc 1995;27 (1 Suppl):34-7.
73. Klotman ME, Hamilton JD. Cytomegalovirus pneumonia. Semin Respir Infect 1987;2:95-103.
74. Marsano L, Perrillo RP, Flye MW, et al. Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 1990;161:454-61.
75. Cleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture technique for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985;21:217-21.
76. Paya CV, Hermans PE, Smith TF, et al. Efficacy of ganciclovir on liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 1988;46:229-34.
77. Shaefer MS, Stratta RJ, et al. Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients. Transplant Proc 1991; 23:1515-6.
78. Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc 1991;23:1498-500.
79. Martin M, Manez R, Linden P, et al. A prospective randomized trial comparing sequential ganciclovir-high-dose acyclovir to high-dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1994;58:779-85.
80. Snydman DR, Werner BG, Dougherty NN, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1993;119:984-91.
81. Snydman DR, Werner BG, Dougherty NN, et al. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG Study Group. Transplant Proc 1994; 26(1 Suppl): 23-7.
82. Plotkin SA, Starr SE, Friedman HM, et al. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. Ann Intern Med 1991;114:525-31.
83. Cane E, Saliba F, Valdecasas G, et al. Efficacy and safety of oral ganciclovir in the prevention of CMV disease in liver transplant recipients: results of a multicenter, multinational clinical trial [abstract]. American Society of Transplant Surgeons, 22nd Annual Scientific Meeting, San Diego, CA, May 1996:47.
84. Breinig MK, Zitelli B, Starzl TE, Ho M. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987;156:273-9.
85. Pohl C, Green M, Wald ER, Ledesma-Medina J. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992;165:166-9.
86. Sable CA, Hayden FG. Orthomyxoviral and paramyxoviral infections in transplant patients. Infect Dis Clin North Am 1995;9:987-1003.
87. Herzog KD, Dunn SP, Langham MR, Marmon LM. Association of parainfluenza virus type 3 infection with allograft rejection in a liver transplant recipient. Pediatr Infect Dis J 1989;8:534-6.
88. Hertz MI, Englund JA, Snover D, Bitterman PB, McGlave PB. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of literature. Medicine (Baltimore) 1989;68:269-81.
89. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066-77.
90. Colombo JL, Sammut PH, Langnas AN, Shaw BW. The spectrum of Pneumocystis carinii infection after liver transplantation in children. Transplantation 1992;54:621-4.
91. Hayes MJ, Torzillo PJ, Sheil AG, McCaughan GW. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transpl 1994;8:499-503.
92. Krowka MJ, Cortese DA. Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med 1989;10:593-616.
93. Patel R, Roberts GD, Keating MR, Paya CV. Infection due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994;19:263-73.
94. Stoblen F, Neuhaus R, Neumann K, et al. Tuberculosis in liver transplant recipients: recurrence after transplantation? Transplant Proc 1994;26:3604-5.
95. Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994;58:301-6.
96. Higgins RM, Cahn AP, Porter D, et al. Mycobacterial infections after renal transplantation. Q J Med 1991;78:145-53.
97. McDiarmid SV, Blumberg DA, Remotti H, et al. Mycobacterial infections after pediatric liver transplantation: a report of three cases and review of the literature. J Pediatr Gastroenterol Nutr 1995;20:425-31.
98. Initial therapy for tuberculosis in the era of multidrug resistance. The recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993;42:1-8.
99. Emond JC. Critical care of liver transplant patients. In: Hall JB, Schmidt GA, Wood LDH, editors. Principles of critical care. New York: McGraw-Hill, 1994:928-46.
100. Spanier TB, Klein RD, Nasraway SA, et al. Multiple organ failure after liver transplantation. Crit Care Med 1995;23:466-73.
101. Nasraway SA, Klein RD, Spanier TB, et al. Hemodynamic correlates of outcome in patients undergoing orthotopic liver transplantation: evidence for early postoperative myocardial depression. Chest 1995;107:218-24.
102. Cosimi AB, Cho SI, Delmonico FL, Kaplan MM, Rohrer RJ, Jenkins RL. A randomized trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation 1987;43:91-5.
103. Costanzo-Nordin MR. Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction. Transplant Proc 1993;25:21-4.
104. Takacka F, Brown MR, Paulsen W, et al. Adult respiratory distress syndrome following orthotopic liver transplantation. Clin Transpl 1989;3:294-9.
105. Powell-Jackson PR, Carmichael FJ, Calne RY, Williams R. Adult respiratory distress syndrome and convulsions associated with administration of cyclosporine in liver transplant recipients. Transplantation 1984;38: 341-3.
106. Costello P, Williams CR, Jenkins RW, et al. The incidence and implications of chest radiographic abnormalities following orthotopic liver transplantation. J Can Assoc Radiol 1987;38:90-5.
107. Judson MA, Sahn SA. The pleural space and organ transplantation. Am J Respir Crit Care Med 1996;153:1153-65.
108. Olutola PS, Hutton L, Wall WJ. Pleural effusion following liver transplantation. Radiology 1985;157:594.
109. Spizarny DL, Gross BH, McLoud T. Enlarging pleural effusion after liver transplantation. J Thorac Imaging 1993;8:85-7.
110. Ellis JE, Lichtor JL, Feinstein SB, et al. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation: a transesophageal two-dimensional echocardiographic study. Anesth Analg 1989;68:777-82.
111. Plevak DJ, Southorn PA, Narr BJ, Peters SG. Intensive-care unit experience in the Mayo liver transplantation program: the first 100 cases. Mayo Clin Proc 1989;64:433-45.
112. Sancho A, Crow J, Mallett SV, et al. Pulmonary platelet aggregates: possible cause of sudden perioperative death in adults undergoing liver transplantation. J Clin Pathol 1993;46:222-7.
113. Gosseye S, van Obbergh L, Weynand B, et al. Platelet aggregates in small lung vessels and death during liver transplantation. Lancet 1991;338:532-4.
114. Miyata T, Yokoyama I, Todo S, Tzakis A, Selby R, Starzl TE. Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989;2:189-91.
115. Winter EM, Pollard AJ, Chapman S, Kelly D, Spencer D. Pulmonary calcification after liver transplantation in children. Br J Radiol 1995; 68:923-5.
116. Libson E, Wechsler RJ, Steiner RM. Pulmonary calcinosis following orthotopic liver transplantation. J Thorac Imaging 1993;8: 305-8.
117. Munoz SJ, Nagelberg SB, Green PJ, et al. Ectopic soft tissue calcium deposition following liver transplantation. Hepatology 1988;8: 476-83.
118. Krowka MJ, Dickson ER, Wiesner RH, Krom RA, Atkinson B, Cortese DA. A prospective study of pulmonary function and gas exchange following liver transplantation. Chest 1992;102:1161-6.
119. Gurakar A, Hassanein T, van Thiel DH, et al. Right diaphragmatic paralysis following orthotopic liver transplantation. J Okla State Med Assoc 1995;88:149-53.
120. McAlister VC, Grant DR, Roy A, et al. Right phrenic nerve injury in orthotopic liver transplantation. Transplantation 1993;55:826-30.
121. Irving L, Angus PW, Pretto JJ, Pierce RJ. Hepatopulmonary syndrome - response to liver transplantation - new insights into an old problem. Aust N Z J Med 1993;23:639-40.
122. Krowka MJ. Hepatopulmonary syndrome. Transplant Proc 1993;25:1746-7.
123. Stoller JK, Lange PA, Westveer MK, Carey WD, Vogt D, Henderson JM. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation: the Cleveland Clinic experience. West J Med 1995;163: 133-8.
124. Lange PA, Stoller JK. The hepatopulmonary syndrome: effect of liver transplantation. Clin Chest Med 1996;17:115-23.
125. Van Thiel DH, Schade RR, Starzl TE, et al. Liver transplantation in adults. Hepatology 1982;2:637-40.
126. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations. Chest 1994;105: 1528-37.
127. Scott V, Miro A, Kang Y, et al. Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation. Transplant Proc 1993;25:1787-8.
128. Eriksson LS, Soderman C, Ericzon BG, Eleborg L, Wahren J, Hedenstierna G. Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: evidence for a hepatopulmonary syndrome. Hepatology 1990;12:1350-7.
129. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-9.
130. Barry S, Pingleton S, Kindscher J, Eisenach J, Forster J. Comparison of shunt fractions pre- and post-liver transplantation. Transplant Proc 1993;25:1801.
131. Schwarzenberg SJ, Freese DK, Regelmann WE, Gores PF, Boudreau RJ, Payne WD. Resolution of severe intrapulmonary shunting after liver transplantation. Chest 1993;103: 1271-3.
132. Hobeika J, Houssin D, Bernard O, Devictor D, Grimon G, Chapuis Y. Orthotopic liver transplantation in children with chronic liver disease and severe hypoxemia. Transplantation 1994;57:224-8.
133. Mews CF, Dorney SF, Sheil AG, Forbes DA, Hill RE. Failure of liver transplantation in Wilson's disease with pulmonary arteriovenous shunting. J Pediatr Gastroenterol Nutr 1990;10:230-3.
134. Oh KS, Bender TM, Bowen A, Ledesma-Medina J. Plain radiographic, nuclear medicine, and angiographic observations of hepatogenic pulmonary angiodysplasia. Pediatr Radiol 1983;13:111-5.
135. Poterucha JJ, Krowka MJ, Dickson ER, Cortese DA, Stanson AW, Krom RA. Failure of hepatopulmonary syndrome to resolve after liver transplantation ad successful treatment with embolectomy. Hepatology 1995; 21:96-100.
136. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1: 106-12.
137. Penn I. Posttransplant malignancies in pediatric organ transplant recipients. Transplant Proc 1994;26:2763-5.
138. Penn I. The changing patterns of posttransplant malignancies. Transplant Proc 1991;23: 1101-3.
139. Penn I. Malignancy. Surg Clin North Am 1994;74:1247-57.
140. Tan-Shalaby J, Tempero M. Malignancies after liver transplantation: a comparative review. Semin Liver Dis 1995;15:156-64.
141. List AF, Greco FA, Vogler LB. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J Clin Oncol 1987;5:1673-89.
142. Bismuth H, Samuel D, Venancie PY, Menouar G, Szekely AM. Development of Kaposi's sarcoma in liver transplant recipients: characteristics, management, and outcome. Transplant Proc 1991;23:1438-9.
143. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990;323:1767-9.
144. Deschler DG, Osorio R, Ascher NL, Lee KC. Posttransplantation lymphoproliferarive disorder in patients under primary tacrolimus (FK 506) immunosuppression. Arch Otolaryngol Head Neck Surg 1995;121:1037-41.
145. Dodd GD III, Ledesma-Medina J, Baron RL, Fuhrman CR. Posttransplant lymphoproliferative disorder: intrathoracic manifestations. Radiology 1992;184:65-9.
146. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-7.
147. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferarive lesions developing under cyclosporin-steroid therapy. Lancet 1984;1:583-7.
148. Reyes J, Tzakis A, Green M, et al. Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc 1991;23:3044-6.